Page last updated: 2024-10-26

valproic acid and Anti-MuSK Myasthenia Gravis

valproic acid has been researched along with Anti-MuSK Myasthenia Gravis in 1 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Research Excerpts

ExcerptRelevanceReference
" Five years later she developed myasthenia gravis, and phenytoin was replaced by valproic acid and phenobarbital."3.68Epilepsy, myasthenia gravis, and effect of plasmapheresis on antiepileptic drug concentrations. ( Jenkins, DC; Lai, CW; Leppik, IE; Sood, P, 1990)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lai, CW1
Leppik, IE1
Jenkins, DC1
Sood, P1

Other Studies

1 other study available for valproic acid and Anti-MuSK Myasthenia Gravis

ArticleYear
Epilepsy, myasthenia gravis, and effect of plasmapheresis on antiepileptic drug concentrations.
    Archives of neurology, 1990, Volume: 47, Issue:1

    Topics: Adult; Anticonvulsants; Combined Modality Therapy; Drug Therapy, Combination; Epilepsy, Temporal Lob

1990